© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
November 19, 2012
November 13, 2012
Can You Read These Rxs?
Pharmacist to Pharmacist
New treatment guidelines are changing the way that clinicians approach hypothyroidism.
A lawsuit turns on whether a pharmacist is exempt from the overtime pay standards of the Federal Fair Labor Standards Act.
In the crackdown on abuse of painkillers, legitimate patients can end up facing undue suspicion.
Generic Times News
Generic Times Product NEWS
Health App Wrap
Mackenzie Clark earns patients' trust.
Frontiers in Pharmacy
Walgreens' new pharmacy model reflects a strong focus on health and wellness.
Pharmacists can debunk the myths and provide the facts about treatment for bronchitis.
November 12, 2012
Merck's Adherence Estimator survey can help health care professionals counsel patients more effectively.
Cough & Cold Watch
Motion sickness is easier to prevent than treat, but OTC options are available.
OTC Case Studies
OTC Product News
The kidneys and liver get a lot of attention when it comes to adverse reactions, but the lungs are susceptible to damage as well.
Interactions with this tyrosine kinase inhibitor arise due to its pharmacokinetic characteristics.
Miscommunication between health care professionals can have dangerous consequences.
Factor V Leiden thrombophilia and the comparative risks of oral anticoagulants are discussed.
Rx Product News Profile
Linzess (linaclotide) is approved for treatment of adults with irritable bowel syndrome with constipation or chronic idiopathic constipation.
Rx Product News
Pharmacist recommendations and intervention can positively impact outcomes for cold patients.
Pharmacists should be aware of the facts and fiction surrounding the use of homeopathic products.
Foster a therapeutic partnership by understanding patients' reasons for nonadherence.
November 09, 2012
Turning an eye to the international stage can be informative and rewarding.
Androgenic alopecia is the only form of hair loss with FDA-approved nonprescription treatments.